Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa
dc.contributor.author | Munita, José | |
dc.contributor.author | Aitken, Samuel | |
dc.contributor.author | Miller, William | |
dc.contributor.author | Perez, Federico | |
dc.contributor.author | Rosa, Rossana | |
dc.contributor.author | Shimose, Luis | |
dc.contributor.author | Lichtenberger, Paola | |
dc.contributor.author | Abbo, Lilian | |
dc.contributor.author | Jain, Rupali | |
dc.contributor.author | Nigo, Masayuki | |
dc.contributor.author | Wanger, Audrey | |
dc.contributor.author | Araos, Rafael | |
dc.contributor.author | Tran, Truc | |
dc.contributor.author | Adachi, Javier | |
dc.contributor.author | Rakita, Robert | |
dc.contributor.author | Shelburne, Samuel | |
dc.contributor.author | Bonomo, Robert | |
dc.contributor.author | Arias, Cesar | |
dc.date.accessioned | 2017-08-30T13:20:45Z | |
dc.date.available | 2017-08-30T13:20:45Z | |
dc.date.issued | 2017 | |
dc.description.abstract | A multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 patients, pneumonia was the most common indication and treatment was successful in 26 (74%). Treatment failure was observed in all cases where isolates demonstrated ceftolozane-tazobactam minimum inhibitory concentrations ≥8 μg/mL. | |
dc.format.extent | 44 | |
dc.identifier.citation | Clinical Infectious Diseases, Volume 65, Issue 1, 1 July 2017, Pages 158–161 | |
dc.identifier.uri | http://hdl.handle.net/11447/1619 | |
dc.identifier.uri | http://dx.doi.org/10.1093/cid/cix014 | |
dc.language.iso | en_US | |
dc.publisher | Oxford University Press | |
dc.subject | ceftolozane | |
dc.subject | carbapenem resistant | |
dc.subject | P. aeruginosa | |
dc.subject | multidrug resistant | |
dc.title | Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa | |
dc.type | Artículo |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Multicenter Evaluation of Ceftolozane-Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa_2.pdf
- Size:
- 178.5 KB
- Format:
- Adobe Portable Document Format
- Description:
- Resumen